Dr. Alane Izu

Alane Izu is a South Africa–based infectious diseases researcher affiliated with Wits VIDA at the University of the Witwatersrand. Her work centers on pediatric infectious diseases, maternal–infant immunity, and vaccine evaluation in low- and middle-income settings. She collaborates extensively on clinical trials and epidemiological studies addressing high-burden pathogens affecting African children.

Her publications highlight expertise in pneumococcal conjugate vaccine schedules, group B Streptococcus immunology and colonization, and measles sero-epidemiology. She has contributed to studies defining correlates of protection, optimizing reduced-dose vaccine strategies, and standardizing immunoassays to support maternal vaccine development. Genomic and surveillance research on Klebsiella pneumoniae and GBS further demonstrates strength in translational microbiology.

Recent work extends to respiratory viruses and tuberculosis, including investigations of RSV and SARS-CoV-2 coinfection severity and trials integrating behavioral and economic interventions to improve TB outcomes. Across studies, her contributions inform vaccine policy, maternal immunization strategies, and public health decision-making in resource-limited settings.